SRL
ALT icon

Scientech Research LLC’s Altimmune ALT Stock Holding History

Scientech Research LLC’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,840
Closed -$67.3K – 242
2026
Q1 		$67.3K Buy
+21,840
New +$92.7K 0.06% 381
2025
Q3 		– Sell
-254,312
Closed -$984K – 572
2025
Q2 		$984K Buy
+254,312
New +$1.38M 0.24% 117

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Scientech Research LLC's ALT Position: Q2 2026 in Review

Scientech Research LLC sold out of Altimmune (ALT) in Q2 2026, closing a stake of 21,840 shares — an estimated $67.3K sold.

Scientech Research LLC first reported a position in ALT in Q2 2025 and held it in 2 quarters. The position peaked at $984K in Q2 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Scientech Research LLC reported no remaining Altimmune position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 21,840 Altimmune shares in Q2 2026, an estimated $67.3K.
  • Scientech Research LLC first reported a position in Altimmune in Q2 2025 and held it in 2 quarters.
  • Scientech Research LLC's Altimmune position peaked at $984K in Q2 2025.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.